Trigyn Technologies Intrinsic Value
TRIGYN Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹82.08 | ₹65.66 - ₹98.50 | +29.8% | EPS: ₹6.84, Sector P/E: 12x |
| Book Value Method | asset | ₹158.07 | ₹142.26 - ₹173.88 | +150.0% | Book Value/Share: ₹239.03, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹126.46 | ₹113.81 - ₹139.11 | +100.0% | Revenue/Share: ₹317.42, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹46.45 | ₹41.81 - ₹51.10 | -26.5% | EBITDA: ₹24.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹155.73 | ₹124.58 - ₹186.88 | +146.3% | CF Growth: 5.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹43.78 | ₹39.40 - ₹48.16 | -30.8% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹56.36 | ₹50.72 - ₹62.00 | -10.9% | Revenue Growth: 6.0%, Adj P/E: 8.2x |
| Graham Defensive Method | conservative | ₹189.69 | ₹170.72 - ₹208.66 | +200.0% | EPS: ₹6.84, BVPS: ₹239.03 |
Want to compare with current market value? Check TRIGYN share price latest .
Valuation Comparison Chart
TRIGYN Intrinsic Value Analysis
What is the intrinsic value of TRIGYN?
Based on our comprehensive analysis using 8 different valuation methods, the estimated intrinsic value of Trigyn Technologies (TRIGYN) is ₹126.46 (median value). With the current market price of ₹63.23, this represents a +100.0% variance from our estimated fair value.
The valuation range spans from ₹43.78 to ₹189.69, indicating ₹43.78 - ₹189.69.
Is TRIGYN undervalued or overvalued?
Based on our multi-method analysis, Trigyn Technologies (TRIGYN) appears to be trading below calculated value by approximately 100.0%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 55.38 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Debt to Equity Ratio | 1.22 | Industry Standard: <0.5 | Above 1.0 | Indicates financial leverage level |
| Return on Equity | 2.7% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | 1.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 1.09x | Industry Standard: 1.0x+ | Above 1.0x | Measures asset utilization efficiency |
Related Pages for Trigyn Technologies
Additional stock information and data for TRIGYN
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹52 Cr | ₹52 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹126 Cr | ₹126 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹-52 Cr | ₹-63 Cr | Negative Cash Flow | 3/10 |
| March 2022 | ₹45 Cr | ₹35 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹80 Cr | ₹76 Cr | Positive Free Cash Flow | 8/10 |